Doctors say Vytorin-cancer link can’t be ruled out

Associated Press
Published: September 2, 2008
Updated: September 2, 2008
» 0 Comments | Post a Comment

MUNICH, Germany (AP) -- Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday. Continue to article.

Share This:

Email Facebook Delicious Digg Twitter Favorites More

Advertisement

 
View More: ,
Not what you're looking for? Try our quick search:
 

Advertisement

Reader Reactions

Post a Comment(Requires free registration)

The commenting period has ended or commenting has been deactivated for this article.

Advertisement

Advertisement

Hey Do This!

Advertisement

Advertisement